The SEC claims that uBiome duped a network of doctors into ordering unnecessary tests. It also alleges that uBiome tricked insurers into paying for tests that weren't medically necessary or properly vetted by medical regulators. Ms Richman was the chief executive officer and Ms Apte was the chief scientific officer of uBiome. Overall, its reported the company took in $US105 million ($NZ147 million) from investors over the years. The SEC claims that uBiome submitted fake chart notes purportedly from doctors to justify the tests.

Source: New Zealand Herald March 21, 2021 19:53 UTC